Benzinga | Nov 10, 2021 08:19AM EST

Aridis Pharmaceuticals Q3 EPS $(1.94) Down From $(0.65) YoY

Aridis Pharmaceuticals (NASDAQ:ARDS) reported quarterly losses of $(1.94) per share. This is a 198.46 percent decrease over losses of $(0.65) per share from the same period last year.